Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Released Mar 14, 2019, after the close
10-K filed Mar 14, 2019, 73 days after period end · 0001640334-19-000379
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$6.22M | -$628.18K | -$1.12M | -$691.18K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 14, 2019 · 73 d after period end
